Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
Acta Neuropathologica Communications|November 7, 2023
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment settingKirsi J Rautajoki, Serafiina Jaatinen, Anja Hartewig, et al.Cancer Research|December 9, 2024
Plasma Cell-Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate CancerJoonatan Sipola, Aslı D Munzur, Edmond M Kwan, et al.Clinical Genitourinary Cancer|May 7, 2019
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205Sebastien J Hotte, Kim N Chi, Anthony M Joshua, et al.European Urology|May 27, 2020
Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate CancerCameron Herberts, Andrew J Murtha, Simon Fu, et al.Cancer Discovery|April 29, 2017
Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of <i>BRCA2</i> Reversion Mutations Associated with Resistance to PARP InhibitorsDavid Quigley, Joshi J Alumkal, Alexander W Wyatt, et al.Nature Medicine|May 27, 2025
Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trialEdmond M Kwan, Sarah W S Ng, Sofie H Tolmeijer, et al.Nature|July 21, 2022
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancerCameron Herberts, Matti Annala, Joonatan Sipola, et al.Nature Cancer|January 4, 2024
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotypingEvan W Warner, Kim Van der Eecken, Andrew J Murtha, et al.JCO Precision Oncology|September 14, 2020
Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort AnalysisAnuradha Jayaram, Anna Wingate, Daniel Wetterskog, et al.Nature|July 31, 2020
Author Correction: The evolutionary history of lethal metastatic prostate cancerGunes Gundem, Peter Van Loo, Barbara Kremeyer, et al.Pageof 7